NewAmsterdam Pharma Company NV Ordinary Shares

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$14.06-$37.07
Market Cap
$3.7B
Shares Short
7M

Financials

See more
Revenue (12 Mos)
$64M
Revenue Growth (YoY)
740.1%
Gross Profit (12 Mos)
$64M
Diluted EPS
-$1.60

News

See more

Yahoo Finance • yesterday

8Dell, 89bio, MBX Biosciences and More Stocks See Action From Activist Investors

Yahoo Finance • 2 months ago

NewAmsterdam Pharma reports Q2 results

Yahoo Finance • 2 months ago

NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results

Yahoo Finance • 2 months ago

Obicetrapib shows promise in reducing Alzheimer's biomarkers

About

CEO
Dr. Michael Harvey Davidson FACC, Facp., M.D.
Address
Gooimeer 2-35, Naarden, Netherlands, 1411 DC
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
68